Purification and characterization of hydantoin racemase from Microbacterium liquefaciens AJ 3912SUZUKI, Shunichi; ONISHI, Norimasa; YOKOZEKI, Kenzo et al.Bioscience, biotechnology, and biochemistry. 2005, Vol 69, Num 3, pp 530-536, issn 0916-8451, 7 p.Article

DIABETES MELLITUS IN A MONGOLOID CHILD WITH CHRONIC DIPHENYLHYDANTOIN THERAPYPAVONE L; MAZZONE D; GRASSO S et al.1982; ACTA PAEDIATR. SCAND.; ISSN 0001-656X; SWE; DA. 1982; VOL. 71; NO 3; PP. 523-524; BIBL. 14 REF.Article

HYPERPLASIE PROVOQUEE PAR LA DIPHENYL-HYDANTOINE CHEZ DES PATIENTS AYANT DES DENTS ET CHEZ DES EDENTES (I)DREYER WP; THOMAS CJ.1982; MED. HYG.; ISSN 0025-6749; CHE; DA. 1982; VOL. 40; NO 1460; PP. 835-837Article

Preserving hydantoin technologyLUTZ, Patrick; CAPPABIANCA, Carl.Global cosmetic industry. 2000, Vol 167, Num 4, pp 38-43, issn 1523-9470, 5 p.Article

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY IN A PATIENT TAKING DIPHENYLHYDANTOINTSUNG SH; LIN JI.1981; ANN. CLIN. LAB. SCI.; ISSN 0091-7370; USA; DA. 1981; VOL. 11; NO 6; PP. 542-545; BIBL. 12 REF.Article

NONSEDATIVE REGIMENS IN THE TREATMENT OF EPILEPSYPORTER RJ; THEODORE WH.1983; ARCHIVES OF INTERNAL MEDICINE (1960); ISSN 0003-9926; USA; DA. 1983; VOL. 143; NO 5; PP. 945-947; BIBL. 29 REF.Article

SINGLE POINT ESTIMATION OF PHENYTOIN DOSING: A REAPPRAISALKOUP JR; GIBALDI M; DODOLPHIN W et al.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 34; NO 2; PP. 231-239; BIBL. 4 REF.Article

THE EFFECTS OF PHENYTOIN ON RAT DEVELOPMENT: AN ANIMAL MODEL SYSTEM FOR FETAL HYDANTOIN SYNDROMELORENTE CA; SHERMAN TASSINARI M; KEITH DA et al.1981; TERATOLOGY; ISSN 0040-3709; USA; DA. 1981; VOL. 24; NO 2; PP. 169-180; BIBL. 37 REF.Article

THE USE OF PHENYTOIN IN NEUROTIC DISORDERS TREATED IN GENERAL PRACTICEHAWARD LRC.1982; CURR: MED. RES. OPIN.; ISSN 0300-7995; GBR; DA. 1982; VOL. 8; NO 2; PP. 134-138; BIBL. 22 REF.Article

COMPLICATIONS HEMATOLOGIQUES INDUITES PAR LES HYDANTOINESGUERIN JM; GUERIN V.1982; MED. INTERNE; ISSN 0025-6781; FRA; DA. 1982; VOL. 17; NO 4; PP. 163-165; BIBL. 18 REF.Article

Determination of mephenytoin stereoselective oxidative metabolism in urine by chiral liquid chromatography employing β-cyclodextrin as a mobile phase additiveRONA, K; SZABO, I.Journal of chromatography. Biomedical applications. 1992, Vol 573, Num 1, pp 173-177, issn 0378-4347Article

NEW EPOXY FAMILY TAKES HIGH FILLER LOADINGS1975; MATER. ENGNG; U.S.A.; DA. 1975; VOL. 82; NO 1; PP. 40-41Article

RECHERCHE DE NOUVEAUX ANTICONVULSIVANTS PARMI DES DERIVES ARYL-3 BENZYLIDENE-5 DE LA THIO-2 HYDANTOINEMUSIAL L; KOROHODA MJ; SZADOWSKA A et al.1972; ACTA POLON. PHARM.; POLOGNE; DA. 1972; VOL. 29; NO 6; PP. 573-581; ABS. RUSSE ANGL.; BIBL. 6REF.Serial Issue

Cloning of D-specific hydantoin utilization genes from Arthrobacter crystallopoietesWERNER, Markus; LAS HERAS VAZQUES, Francisco Javier; FRITZ, Christina et al.Engineering in life sciences (Print). 2004, Vol 4, Num 6, pp 563-572, issn 1618-0240, 10 p.Conference Paper

Hospitalizations for pulmonary reactions following nitrofurantoin useJICK, S. S; JICK, H; WALKER, A. M et al.Chest. 1989, Vol 96, Num 3, pp 512-515, issn 0012-3692Article

Hypoglycemic activity of aldose reductase inhibitor, 1-[(p-bromophenyl)sulfonyl]hydantoinMIWA, I; INAGAKI, K; YASHIRO, T et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 5, pp 2030-2032, issn 0009-2363Article

Phenytoinkinetik bei toxischen Serumspiegel = Pharmacocinétique de la phénytoïne dans des cas de taux sériques toxiques = Phenytoïn kinetics in toxic plasma levelsBEIER, R; ZSCHIESCHE, M; FRANKE, G et al.Psychiatrie, Neurologie und medizinische Psychologie. 1983, Vol 35, Num 8, pp 471-478, issn 0033-2739Article

DERIVES INSATURES DE L'HYDANTOINE. VI. EFFET DE LA C DE L'ALCALI SUR LA V DE LA TRANSPOSITION DE LA CARBOXYMETHYLIDENE-5-HYDANTOINE EN ACIDE OROTIQUEIVIN VA; RUTKOVSKIJ GV; SOCHILIN EG et al.1972; ZH. ORG. KHIM.; S.S.S.R.; DA. 1972; VOL. 8; NO 9; PP. 1951-1960; BIBL. 15 REF.Serial Issue

Ethotoin in seizures of childhood and adolescenceCARTER, C. A; HELMS, R. A; BOEHM, R et al.Neurology. 1984, Vol 34, Num 6, pp 791-795, issn 0028-3878Article

Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patientsBAUER, L. A; BLOUIN, R. A.Clinical pharmacokinetics. 1983, Vol 8, Num 6, pp 545-549, issn 0312-5963Article

EFFECTS OF 3,5-DIETHYLHYDANTOIN ON RESISTANCE TO ASPHYXIA IN RATSSHEMANO I; ORZECHOWSKI R; GOLDSTEIN S et al.1973; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1973; VOL. 25; NO 2; PP. 250-258; BIBL. 8REF.Article

Effects of diphenylhydantoin on behavior maintained by a multiple schedule of food reinforcementMEUNIER, G. F; FISCHER, R. B; MULVANEY, D et al.Psychological reports. 1983, Vol 52, Num 3, pp 779-783, issn 0033-2941Article

Study of the pyrolysis of sludge and sludge/disposal filter cake mix for the production of value added productsVELGHE, Inge; CARLEER, Robert; YPERMAN, Jan et al.Bioresource technology. 2013, Vol 134, pp 1-9, issn 0960-8524, 9 p.Article

Deducing the Bioactive Face of Hydantoin Anticonvulsant Drugs Using NMR SpectroscopyTIEDJE, Kathryn E; WEAVER, Donald F.Canadian journal of neurological sciences. 2008, Vol 35, Num 2, pp 232-236, issn 0317-1671, 5 p.Article

A new cyclic N-halamine biocidal polymerGANG SUN; WHEATLEY, W. B; WORLEY, S. D et al.Industrial & engineering chemistry research. 1994, Vol 33, Num 1, pp 168-170, issn 0888-5885Article